p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation
- PMID: 9661907
p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation
Abstract
Expression of mutated versions of the p53 gene deranged the differentiation program of thyroid cells and resulted in deregulated growth. Specifically, p53 mutants in several residues of the DNA-binding region induced thyrotropin (TSH) -independent growth and inhibition of the expression of thyroid-specific genes. The loss of the differentiated phenotype invariably correlated with the blockage of the expression of the genes coding for the thyroid transcriptional factors PAX-8 and TTF2. Conversely, thyroid cells transfected with a p53 gene mutated at codon 392, located outside the DNA-binding region, stimulated the expression of differentiation genes in the absence of the TSH, and induced TSH-independent growth. cAMP intracellular levels were higher in thyroid cells transfected with the p53 gene mutated at the 392 site than in the untransfected thyroid cells, but lower in the cells transfected with the other mutated p53 genes. Fra-1 and c-jun were induced by p53, resulting in increased AP-1 levels. The results of this study suggest that p53 exerts effects on cAMP transduction pathway in thyroid cells, which are exquisitely sensitive to cAMP.
Similar articles
-
p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.Oncogene. 1997 Feb 13;14(6):729-40. doi: 10.1038/sj.onc.1200887. Oncogene. 1997. PMID: 9038381
-
Contrasting effects of activating mutations of GalphaS and the thyrotropin receptor on proliferation and differentiation of thyroid follicular cells.Oncogene. 1999 Aug 26;18(34):4798-807. doi: 10.1038/sj.onc.1202864. Oncogene. 1999. PMID: 10490813
-
Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.J Cell Physiol. 1999 Nov;181(2):342-54. doi: 10.1002/(SICI)1097-4652(199911)181:2<342::AID-JCP16>3.0.CO;2-K. J Cell Physiol. 1999. PMID: 10497313
-
The cAMP in thyroid: from the TSH receptor to mitogenesis and tumorigenesis.Adv Second Messenger Phosphoprotein Res. 1997;31:125-40. Adv Second Messenger Phosphoprotein Res. 1997. PMID: 9344247 Review. No abstract available.
-
[Advances in the research on anti-oncogenes P53].Sheng Li Ke Xue Jin Zhan. 1993 Apr;24(2):137-8. Sheng Li Ke Xue Jin Zhan. 1993. PMID: 8211064 Review. Chinese. No abstract available.
Cited by
-
Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?Front Endocrinol (Lausanne). 2021 Feb 25;12:623182. doi: 10.3389/fendo.2021.623182. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716974 Free PMC article.
-
Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization.Mol Cell Biol. 2003 Jun;23(12):4401-15. doi: 10.1128/MCB.23.12.4401-4415.2003. Mol Cell Biol. 2003. PMID: 12773579 Free PMC article.
-
Targeted therapies in thyroid cancer.Target Oncol. 2009 Dec;4(4):275-85. doi: 10.1007/s11523-009-0124-y. Epub 2009 Nov 11. Target Oncol. 2009. PMID: 19904500
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous